Key references: Glucocorticoid-induced hyperglycaemia

American Diabetes Association. 14. Diabetes care in the hospital: Standards of medical care in diabetes-2018. Diabetes Care 2018;41(Suppl 1):S144–S51. https://www.ncbi.nlm.nih.gov/pubmed/29222385
Brady V, Thosani S, Zhou S, Bassett R, Busaidy NL, Lavis V. Safe and effective dosing of basal-bolus insulin in patients receiving high-dose steroids for hyper-cyclophosphamide, doxorubicin, vincristine, and dexamethasone chemotherapy. Diabetes Technol Ther 2014;16(12):874–9. https://www.ncbi.nlm.nih.gov/pubmed/25321387
Burt MG, Willenberg VM, Petersons CJ, Smith MD, Ahern MJ, Stranks SN. Screening for diabetes in patients with inflammatory rheumatological disease administered long-term prednisolone: a cross-sectional study. Rheumatology (Oxford) 2012;51(6):1112–9. https://www.ncbi.nlm.nih.gov/pubmed/22332121
Choudhry MN, Malik RA, Charalambous CP. Blood glucose levels following intra-articular steroid injections in patients with diabetes: A systematic review. JBJS Rev 2016;4(3). https://www.ncbi.nlm.nih.gov/pubmed/27500431
Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C. Drug-induced hyperglycaemia and diabetes. Drug Saf 2015;38(12):1153–68. https://www.ncbi.nlm.nih.gov/pubmed/26370106
Joint British Diabetes Societies for Inpatient Care. Management of hyperglycaemia and steroid (glucocorticoid) therapy. London: Diabetes UK; 2014. https://www.diabetes.org.uk/for-professionals/improving-care/good-practice/inpatient-and-hospital-care/joint-british-diabetes-society-for-inpatient-care
Kwon S, Hermayer KL. Glucocorticoid-induced hyperglycemia. Am J Med Sci 2013;345(4):274–7. https://www.ncbi.nlm.nih.gov/pubmed/23531958
Perez A, Jansen-Chaparro S, Saigi I, Bernal-Lopez MR, Minambres I, Gomez-Huelgas R. Glucocorticoid-induced hyperglycemia. J Diabetes 2014;6(1):9–20. https://www.ncbi.nlm.nih.gov/pubmed/24103089
Radhakutty A, Stranks JL, Mangelsdorf BL, Drake SM, Roberts GW, Zimmermann AT, et al. Treatment of prednisolone-induced hyperglycaemia in hospitalized patients: Insights from a randomized, controlled study. Diabetes Obes Metab 2017;19(4):571–8. https://www.ncbi.nlm.nih.gov/pubmed/27995731
Ruiz de Adana MS, Colomo N, Maldonado-Araque C, Fontalba MI, Linares F, Garcia-Torres F, et al. Randomized clinical trial of the efficacy and safety of insulin glargine vs. NPH insulin as basal insulin for the treatment of glucocorticoid induced hyperglycemia using continuous glucose monitoring in hospitalized patients with type 2 diabetes and respiratory disease. Diabetes Res Clin Pract 2015;110(2):158–65. https://www.ncbi.nlm.nih.gov/pubmed/26474657
Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2012;97(1):16–38. https://www.ncbi.nlm.nih.gov/pubmed/22223765